- Solid Tumors
- Pipeline Molecules
- Alliance Partners
Our mission is to provide healthcare professionals with unbiased clinical research information, easily.
Currently, you can access the following clinical trials being conducted worldwide:
Clinicaltrials.gov identifier NCT03927820
Recruitment Status Recruiting
First Posted April 25, 2019
Last update posted July 9, 2020
The goal of this study is to assess the impact of pharmacist-led benefits investigations and application of clinical practice guidelines on patient access to inhalers and time to hospital readmission or Emergency Department (ED) visit.
|: Patients Using Inhalers
Adult patient admitted to Vanderbilt University Medical Center (excluding surgery services) on a long acting inhaler or prescribed a long acting inhaler during admission.
Other: Benefits investigation
The study pharmacist will review the prescribed inhaler for 1) insurance coverage and 2) clinical appropriateness. The pharmacist will conduct a benefits investigation at time of hospital admission. The benefits investigation involves running test claims for inhalers to determine the most cost-effective inhaler for the patient's insurance plan. The study pharmacist will utilize clinical practice guidelines to assess appropriateness of the prescribed inhaler. Based on this review, the study pharmacist will submit a pharmacy consult to the inpatient pharmacist on the patient's healthcare team who will pend the inhaler orders (changing the patient's prescribed inhaler, if necessary) for the prescriber to send to the Meds to Beds discharge pharmacy. The Meds to Beds pharmacist will counsel the patient on inhaler use techniques prior to discharge.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, , Learn About Clinical Studies.-->
- Adult patient admitted to Vanderbilt University Medical Center (VUMC) (excluding
- on a long acting inhaler or prescribed a long acting inhaler during admission.
- Diagnosis of cystic fibrosis
- Diagnosis of graft versus host disease (GVHD)
- no medication insurance
- discharge to any post-acute care facility or inpatient hospice
- death during hospitalization
Contact: Kristina Niehoff, PharmD 615-322-3921 email@example.com
United States, Tennessee
Vanderbilt Univeristy Medical Center
Vanderbilt University Medical Center
Principal Investigator: Kristina Niehoff, PharmD Vanderbilt University Medical Center